Hourvitz Ariel, Kuwahara Akira, Hennebold Jon D, Tavares Adriano B, Negishi Hiroaki, Lee Taek Hoo, Erickson Gregory F, Adashi Eli Y
Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Huntsman Cancer Institute, 2000 Circle of Hope, Rm 5221, Salt Lake City, UT 84112, USA.
Endocrinology. 2002 May;143(5):1833-44. doi: 10.1210/endo.143.5.8769.
Compelling evidence exists displaying that the intrafollicular IGF-I system constitutes an obligatory mediator of FSH action in the murine ovary. Within this system, the ovarian IGF binding protein-4-directed protease (IGFBP-4ase) may have a critical role. Human IGFBP-4ase has been proved identical to the previously well-characterized pregnancy-associated plasma protein-A (PAPP-A). This communication reports the cloning and sequencing of the mouse PAPP-A cDNA as well as its expression and cellular localization in the mouse ovary. PAPP-A mRNA was undetectable in ovaries of untreated immature 25-d-old mice. Treatment with PMSG led to a marked time-dependent increase in PAPP-A expression in well-defined subsets of granulosa cells and follicles. Specifically, PAPP-A expression was detectable exclusively in centrifugally residing membrana granulosa cells of antral follicles during a 3- to 36-h period post PMSG. PAPP-A expression then fell to nondetectable levels in dominant preovulatory follicles at 48 h post PMSG. Treatment of PMSG-primed mice with human CG caused a rapid reinduction of PAPP-A expression in granulosa cells of dominant follicles and was sustained at relatively high levels throughout the ovulation and luteinization. These results suggest a role for gonadotropin-stimulated PAPP-A gene expression in the physiologic processes of dominant follicle development, ovulation, and luteogenesis in the mammalian ovary. The early onset and extended duration of gonadotropin-dependent PAPP-A expression in granulosa cells may serve to degrade the antigonadotropin IGFBP-4. Accordingly, successful antral follicle development, ovulation, and corpus luteum formation may be contingent on an IGFBP-4-deplete/PAPP-A-replete circumstance, hence resulting in an IGF-I-replete intrafollicular microenvironment.
有确凿证据表明,卵泡内胰岛素样生长因子-I(IGF-I)系统是小鼠卵巢中促卵泡激素(FSH)作用的必需介质。在该系统中,卵巢胰岛素样生长因子结合蛋白-4导向蛋白酶(IGFBP-4ase)可能起关键作用。已证明人IGFBP-4ase与先前已充分表征的妊娠相关血浆蛋白-A(PAPP-A)相同。本通讯报道了小鼠PAPP-A cDNA的克隆和测序,以及其在小鼠卵巢中的表达和细胞定位。在未处理的25日龄未成熟小鼠的卵巢中未检测到PAPP-A mRNA。用孕马血清促性腺激素(PMSG)处理导致颗粒细胞和卵泡的明确亚群中PAPP-A表达随时间显著增加。具体而言,在PMSG后3至36小时期间,仅在窦状卵泡的离心性驻留颗粒细胞膜细胞中可检测到PAPP-A表达。然后,在PMSG后48小时,优势排卵前卵泡中的PAPP-A表达降至不可检测水平。用人绒毛膜促性腺激素(hCG)处理PMSG预处理的小鼠,导致优势卵泡颗粒细胞中PAPP-A表达迅速重新诱导,并在整个排卵和黄体化过程中维持在相对较高水平。这些结果表明,促性腺激素刺激的PAPP-A基因表达在哺乳动物卵巢优势卵泡发育、排卵和黄体生成的生理过程中起作用。颗粒细胞中促性腺激素依赖性PAPP-A表达的早期开始和延长持续时间可能有助于降解抗促性腺激素IGFBP-4。因此,成功的窦状卵泡发育、排卵和黄体形成可能取决于IGFBP-4耗尽/PAPP-A充足的情况,从而导致卵泡内IGF-I充足的微环境。